Fundraising FoxClavystBio — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
65LAB accelerates drug discovery and therapeutic company formation by connecting academic research institutions, life science investors, and Evotec to develop novel medicines into commercial entities.
BiotechDeep TechSingapore, SG
BoardSteve Courtney(Expert in Residence)
Co-investorsLightstone VenturesLeaps by Bayer
Automera develops an autophagy-powered small molecule degrader platform designed to accelerate drug development and reduce costs in therapeutic creation.
AI & Machine LearningBiotechDeep Tech
Zian-Loong Wang(Chief Technology Officer & Co-Founder)Michael Lazarou(Co-Founder)inThong Q. Le(Chief Executive Officer)in
Co-investorsACCELERATOR LIFE SCIENCE PARTNERSXora Innovation Pte Ltd
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.